Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01791816 · ClinicalTrials.gov registry record · Early Phase 1
Mechanisms of Vasovagal Syncope
A Early Phase 1 study, sponsored by New York Medical College.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 90
- Enrollment target
NCT01791816 is a Early Phase 1 study that has completed, run by New York Medical College. The registered enrollment target is 90 participants.
The verdict
NCT01791816, a Early Phase 1 study, has completed, sponsored by New York Medical College.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 90 participants
- Enrollment target
Study Summary
Vasovagal Syncope (simple postural faint) is the most common cause of acute loss of consciousness. Postural tachycardia syndrome(POTS) is the most common chronic form of postural lightheadedness. Together they afflict many Americans, mostly young women, who are prevented from gainful employ or school attendance. The underlying mechanism is not known. Our past work suggests that a simple molecule, nitric oxide, acts to subvert normal blood flow controls causing blood to pool in the gut when standing. Our proposal will show the mechanism behind this problem and will indicate effective medical treatments. Patients will be compared to healthy control subjects.
Interventions
- DRUG Phenylephrine
- DRUG L-Ng-monomethyl Arginine (L-NMMA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2013-02 |
| Est. Completion | 2022-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01791816
The ClinicalTrials.gov registry entry for NCT01791816 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York Medical College, which has 47 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Phenylephrine is the first listed.
NCT01791816 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01791816 about?
NCT01791816 is a clinical study titled "Mechanisms of Vasovagal Syncope". Vasovagal Syncope (simple postural faint) is the most common cause of acute loss of consciousness. Postural tachycardia syndrome(POTS) is the most common chronic form of postural lightheadedness. Together they afflict many Americans, mostly young women, who are prevented from gainful employ or schoo...
What is the current status of trial NCT01791816?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 90 participants. The study started on 2013-02. Estimated completion is 2022-12.
What interventions are being tested in trial NCT01791816?
The interventions under investigation include: Phenylephrine (DRUG), L-Ng-monomethyl Arginine (L-NMMA) (DRUG).
Who is sponsoring clinical trial NCT01791816?
This trial is sponsored by New York Medical College, which has 47 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.